ENTITY

Voyager Therapeutics (VYGR US)

3
Analysis
Health Care • United States
Voyager Therapeutics, Inc. operates as a clinical-stage gene therapy company. The Company focuses on developing life-changing treatments for patients suffering from severe diseases of the central nervous system. Voyager Therapeutics develops gene therapies for fatal and debilitating diseases.
more
Exchange Announcement • 07 Aug 2026 04:03

Current Report (Form 8-K | Period ending 2026-08-06)

Exchange Announcement • 06 Aug 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 13 Jul 2026 20:44

Current Report (Form 8-K | Period ending 2026-07-13)

Exchange Announcement • 11 Jun 2026 04:05

Current Report (Form 8-K | Period ending 2026-06-09)

Exchange Announcement • 01 Jun 2026 20:00

Current Report (Form 8-K | Period ending 2026-06-01)

x